Improved Biomedical and Psychological Outcomes 1 Year After Structured Education in Flexible Insulin Therapy for People With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: DAFNE (Dose Adjustment For Normal Eating), a structured education program in flexible insulin therapy, has been widely adopted in the U.K. after validation in a randomized trial. To determine benefits in routine practice, we collected biomedical and psychological data from all participants attending during a 12-month period. RESEARCH DESIGN AND METHODS: HbA1c, weight, self-reported hypoglycemia awareness, severe hypoglycemia frequency, PAID (Problem Areas In Diabetes), HADS (Hospital Anxiety and Depression Scale), and EuroQol Group 5-Dimension Self-Report Questionnaire scores were recorded prior to DAFNE and after 1 year. RESULTS: Complete baseline and follow-up HbA1c data were available for 639 (54.9%) of 1,163 attendees. HbA1c fell from 8.51 ± 1.41 (mean ± SD) to 8.24 ± 1.29% (difference 0.27 [95% CI 0.16–0.38]; P < 0.001), with a greater mean fall of 0.44% from baseline HbA1c >8.5%. Severe hypoglycemia rate fell from 1.7 ± 8.5 to 0.6 ± 3.7 episodes per person per year (1.1 [0.7–1.4]) and hypoglycemia recognition improved in 43% of those reporting unawareness. Baseline psychological distress was evident, with a PAID score of 25.2 and HADS scores of 5.3 (anxiety) and 4.8 (depression), falling to 16.7 (8.5 [6.6–10.4]), 4.6 (0.7 [0.4–1.0]), and 4.2 (0.6 [0.3–0.8]), respectively (all P < 0.001 at 1 year). Clinically relevant anxiety and depression (HADS ≥8) fell from 24.4 to 18.0% and 20.9 to 15.5%, respectively. CONCLUSIONS: A structured education program delivered in routine clinical practice not only improves HbA1c while reducing severe hypoglycemia rate and restoring hypoglycemia awareness but also reduces psychological distress and improves perceived well-being.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [105]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recurrent level 2 hypoglycemia and/or level 3 hypoglycemia is an urgent medical issue and requires intervention with medical treatment plan adjustment, behavioral intervention, and, in some cases, use of technology to assist with hypoglycemia prevention and identification (76,(79)(80)(81)(82).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [82]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those responding, “less than 3.0 mmol/L (54 mg/dL)” or not experiencing symptoms have a >4-fold increased risk of level 3 hypoglycemia (120).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These programs have been successfully delivered in other settings (103,104) with comparable reductions in hypoglycemic risk (105).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [105]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Conversely, some individuals with type 1 diabetes or type 2 diabetes and hypoglycemia who have a fear of hyperglycemia are resistant to relaxation of glycemic targets (74)(75)(76)(77)(78)(79)(80)(81)(82)(83).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [82]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Assessment of Diabetes-Related Distress
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Welch, G., Jacobson, A. M., Aponte, J. E., & Schwartz, C. E. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.754 · Cited by 1,497 · cited 1×
“Psychological assessment included three well-validated measures of psychological well-being relevant to diabetes: the EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D), a generic measure of quality of life (4); the Hospital Anxiety and Depression Scale (HADS), a screening tool for evidence of anxiety and dep…”
Method(2002) · BMJ · doi:10.1136/bmj.325.7367.746 · Cited by 916 · cited 2×
“program was tested in a three-center randomized controlled trial (RCT) in which DAFNE training was associated with clinically relevant improvements in HbA1c and in aspects of quality of life specific to diabetes (3).”
MethodAmiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723
Self-citationSnoek, F. J., Pouwer, F., Welch, G. W., & Polonsky, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1305 · Cited by 444
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Self-citationFanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Research works printed but not linked: 1
- Campbell MJ, Machin D, Walters SJ. Common pitfalls. In Medical Statistics: A Textbook for the Health Sciences 4th ed. West Sussex, U.K., Wiley, 2007, p. 278–296
Cited by
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s006 · Cited by 1,403
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
“These programs have been successfully delivered in other settings (103,104) with comparable reductions in hypoglycemic risk (105).”
BackgroundSelf-citationType 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M. B., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 965
“Patient education (80), frequent SMBG, and CGM can help detect hypoglycemia and allow for adjustments in insulin dosing and carbohydrate intake.”
Background6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s006 · Cited by 744
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“0 mmol/L (54 mg/dL)” or not experiencing symptoms have a >4-fold increased risk of level 3 hypoglycemia (120).”
6. Glycemic Targets: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s006 · Cited by 684
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645
“T1D (3,4), confers a threefold to sixfold”
Background6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
“0 mmol/l (54 mg/dl)’ or not experiencing symptoms have a >4-fold increased risk of Level 3 hypoglycaemia [120].”
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4127 · Cited by 412
Self-citationFunctional Foods and Lifestyle Approaches for Diabetes Prevention and Management
Alkhatib, A., Tsang, C., Tiss, A., Bahorun, T., Arefanian, H., Barake, R., Khadir, A., & Tuomilehto, J. (2017) · Nutrients · doi:10.3390/nu9121310 · Cited by 376
Diabetes structured self-management education programmes: a narrative review and current innovations
Chatterjee, S., Davies, M. J., Heller, S., Speight, J., Snoek, F. J., & Khunti, K. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30239-5 · Cited by 372
Self-citationDiabetes distress among adolescents with type 1 diabetes: a systematic review
Hagger, V., Hendrieckx, C., Sturt, J., Skinner, T. C., & Speight, J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0694-2 · Cited by 338
9. pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 263
Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia
Cryer, P. E. (2014) · Diabetes · doi:10.2337/db14-0059 · Cited by 236
“Even an episode of severe hypoglycemia with a history of hypoglycemia unawareness, which dictates some action (1), might not force an immediate higher glycemic goal until one has tried patient reeducation (1,64) and a 2–3 week trial of scrupulous avoidance of hypoglycemia (1,65–68) with the anticipation that these mig…”
BackgroundLittle, S. A., Leelarathna, L., Walkinshaw, E., Tan, H. K., Chapple, O., Lubina-Solomon, A., Chadwick, T. J., Barendse, S., Stocken, D. D., Brennand, C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0030 · Cited by 237
Self-citationAbraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
“• Diabetes education is critical to preventing hypoglycemia (A).(4) • Education about the risk factors for hypoglycemia should be given”
Choudhary, P., Rickels, M. R., Senior, P. A., Vantyghem, M.-C., Maffi, P., Kay, T. W., Keymeulen, B., Inagaki, N., Saudek, F., Lehmann, R., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0090 · Cited by 233
“For certain patients with behavioral issues, further behavioral programs such as BGAT, HyPOS, or DAFNE-HART may be beneficial.”
BackgroundMethodInfluentialMinimizing Hypoglycemia in Diabetes
International Hypoglycaemia Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0279 · Cited by 209
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Psychological conditions in adults with diabetes.
de Groot, M., Golden, S. H., & Wagner, J. (2016) · American Psychologist · doi:10.1037/a0040408 · Cited by 170
“Small, controlled trials of mindfulness-based cognitive therapy (van Son et al., 2013), as well as diabetes education, self-management training, and psychoeducation have all shown benefits for anxiety in patients with T1D (Hopkins et al., 2012) and T2D (Penckofer et al., 2012).”
BackgroundChoudhary, P., Ramasamy, S., Green, L., Gallen, G., Pender, S., Brackenridge, A., Amiel, S. A., & Pickup, J. C. (2013) · Diabetes Care · doi:10.2337/dc13-0939 · Cited by 160
“Structured education in flexible insulin therapy can significantly reduce SH and restore awareness in almost half of those who report unawareness (8).”
BackgroundSelf-citationThe detection and management of diabetes distress in people with type 1 diabetes
Sturt, J., Dennick, K., Due-Christensen, M., & McCarthy, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0660-z · Cited by 157
Structured Type 1 Diabetes Education Delivered Within Routine Care
Cooke, D., Bond, R., Lawton, J., Rankin, D., Heller, S., Clark, M., Speight, J., & for the U.K. NIHR DAFNE Study Group (2013) · Diabetes Care · doi:10.2337/dc12-0080 · Cited by 156
“Statistically, the improvement in glycemic control was only slightly reduced by 12 months, mirroring the DAFNE RCT, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the EURODIAB cohort, and the DAFNE Database Study (2,5,6,14).”
BackgroundResultSelf-citationYeoh, E., Choudhary, P., Nwokolo, M., Ayis, S., & Amiel, S. A. (2015) · Diabetes Care · doi:10.2337/dc15-0102 · Cited by 154
“All of these approaches, based on adult learning principles, resulted in significant reductions in SH rates of between 15% and 75% in four studies (4,21,22,24), with one showing a trend toward a lower frequency of low BG readings that was not statistically significant (25).”
BackgroundMethodInfluentialSelf-citationBosi, E., Choudhary, P., de Valk, H. W., Lablanche, S., Castañeda, J., de Portu, S., Da Silva, J., Ré, R., Vorrink-de Groot, L., Shin, J., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30150-0 · Cited by 125
Sherr, J. L., Laffel, L. M., Liu, J., Wolf, W., Bispham, J., Chapman, K. S., Finan, D., Titievsky, L., Liu, T., Hagan, K., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1765 · Cited by 99
Elliott, J., Jacques, R. M., Kruger, J., Campbell, M. J., Amiel, S. A., Mansell, P., Speight, J., Brennan, A., & Heller, S. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12441 · Cited by 112
Self-citationLi, J., Huang, J., Zheng, L., & Li, X. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00173 · Cited by 122
“However, despite this recognition, most of the evidence relevant to this topic was obtained from before-and-after comparisons of patients with uncontrolled diabetes or from non-randomized control studies (18, 19).”
BackgroundCurrent Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Moon, S. J., Jung, I., & Park, C.-Y. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0177 · Cited by 98
“However, the reality is that the process is neither easy nor comfortable [9].”
BackgroundNew advances in type 1 diabetes
Subramanian, S., Khan, F., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 88
Rossi, M. C., Nicolucci, A., Lucisano, G., Pellegrini, F., Di Bartolo, P., Miselli, V., Anichini, R., & Vespasiani, O. B. O. T. D. S. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0021 · Cited by 103
Insulin adherence in patients with diabetes: risk factors for injection omission
Farsaei, S., Radfar, M., Heydari, Z., Abbasi, F., & Qorbani, M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.03.001 · Cited by 106
A Psychoeducational Program to Restore Hypoglycemia Awareness: The DAFNE-HART Pilot Study
de Zoysa, N., Rogers, H., Stadler, M., Gianfrancesco, C., Beveridge, S., Britneff, E., Choudhary, P., Elliott, J., Heller, S., & Amiel, S. A. (2014) · Diabetes Care · doi:10.2337/dc13-1245 · Cited by 103
“Participants were taught to look for hypoglycemia cues and consider their own causes and consequences of IAH and how to reduce hypoglycemia exposure.”
BackgroundMethodInfluentialSelf-citationHermanns, N., Kulzer, B., Ehrmann, D., Bergis-Jurgan, N., & Haak, T. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.009 · Cited by 105
Effects of advanced carbohydrate counting in patients with Type 1 diabetes: a systematic review
Schmidt, S., Schelde, B., & Nørgaard, K. (2014) · Diabetic Medicine · doi:10.1111/dme.12446 · Cited by 94
Lawton, J., Rankin, D., Elliott, J., Heller, S. R., Rogers, H. A., De Zoysa, N., Amiel, S., & for the U.K. NIHR DAFNE Study Group (2014) · Diabetes Care · doi:10.2337/dc13-1154 · Cited by 87
“Given the issues raised in this study, it is clear that clinical effort should continue to be directed toward diagnosing HU and offering effective interventions to help patients restore awareness of hypoglycemia (22).”
BackgroundSelf-citationLittle, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Chadwick, T. J., Stocken, D. D., Brennand, C., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2682 · Cited by 86
Self-citationLin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
Ramadan and Diabetes: A Narrative Review and Practice Update
Ahmed, S. H., Chowdhury, T. A., Hussain, S., Syed, A., Karamat, A., Helmy, A., Waqar, S., Ali, S., Dabhad, A., Seal, S. T., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00886-y · Cited by 87
“Regarding the general management of T1 diabetes, the Dose Adjustment for Normal Eating (DAFNE) programme, an educational course for managing T1 diabetes, has been shown to reduce severe hypoglycaemia and hyperglycaemia and improve the quality of life of participants [101, 102].”
BackgroundMoon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
The role of structured education in the management of hypoglycaemia
Iqbal, A., & Heller, S. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4334-z · Cited by 78
“However, the DAFNE authors did establish a robust definition for IAH in the form of a hypoglycaemia awareness rating that may be less subjective than the Gold score [31, 33].”
BackgroundSelf-citationRiemsma, R., Corro Ramos, I., Birnie, R., Büyükkaramikli, N., Armstrong, N., Ryder, S., Duffy, S., Worthy, G., Al, M., Severens, J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20170 · Cited by 73
Current state and future evolution of pancreatic islet transplantation
Anazawa, T., Okajima, H., Masui, T., & Uemoto, S. (2019) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12214 · Cited by 77
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement
Bartlett, S. T., Markmann, J. F., Johnson, P., Korsgren, O., Hering, B. J., Scharp, D., Kay, T. W. H., Bromberg, J., Odorico, J. S., Weir, G. C., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001055 · Cited by 75
“Forty percent of the patients referred to the UK Dose Adjustment for Normal Eating program have impaired awareness of hypoglycemia, which is restored in 40% of those 1 year after UK Dose Adjustment for Normal Eating.(190) Meta-analysis shows that insulin pump therapy can provide a 4-fold reduction in the rate of sever…”
BackgroundBakhach, M., Reid, M. W., Pyatak, E. A., Berget, C., Cain, C., Thomas, J. “., Klingensmith, G. J., & Raymond, J. K. (2019) · The Diabetes Educator · doi:10.1177/0145721719858080 · Cited by 73
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.004 · Cited by 71
Peasgood, T., Brennan, A., Mansell, P., Elliott, J., Basarir, H., & Kruger, J. (2016) · Medical Decision Making · doi:10.1177/0272989x16658660 · Cited by 66
“This can be found in Hopkins and others.(26) If individuals did not report a complication, it is assumed that they do not have one (this arose for about a third of cases that had EQ-5D data).”
BackgroundMethodSelf-citationSpeight, J., Holmes-Truscott, E., Harvey, D. M., Hendrieckx, C., Hagger, V. L., Harris, S. E., Knight, B. A., & McIntyre, H. D. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.002 · Cited by 61
Thabit, H., & Hovorka, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1115013 · Cited by 58
“Normal Eating (DAFNE) in the UK, which are delivered by trained diabetes educators, have shown benefits in glycaemic control and QOL.[66,67] Optimisation of MDI”
BackgroundIqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 64
“Similar falls in severe hypoglycaemia rates have also been reported following participation in a UK adaptation of a similar skills based training course (Dose Adjustment for Normal Eating (DAFNE) course (103), suggesting that structured training courses teaching people to use insulin safely leads to clinically relevan…”
BackgroundSelf-citationFegan‐Bohm, K., Minard, C. G., Anderson, B. J., Butler, A. M., Titus, C., Weissberg-Benchell, J. A., & Hilliard, M. E. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13108 · Cited by 61
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Beato‐Víbora, P., Yeoh, E., Rogers, H., Hopkins, D., Amiel, S. A., & Choudhary, P. (2015) · Diabetic Medicine · doi:10.1111/dme.12869 · Cited by 55
Self-citationDefective Counterregulation and Hypoglycemia Unawareness in Diabetes
Reno, C. M., Litvin, M., Clark, A. L., & Fisher, S. J. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.005 · Cited by 53
Cook, A. J., DuBose, S. N., Foster, N., Smith, E. L., Wu, M., Margiotta, G., Rickels, M. R., Speight, J., de Zoysa, N., & Amiel, S. A. (2019) · Diabetes Care · doi:10.2337/dc19-0002 · Cited by 52
“Following the pathway for themanagement of hypoglycemia in T1D (14), some people regain awareness with educational and psychoeducational programs such as Dose Adjustment For Normal Eating (DAFNE) and HypoCOMPaSS (15,16), yet others continue with IAH and SH (9).”
BackgroundSelf-citationHeller, S., Lawton, J., Amiel, S., Cooke, D., Mansell, P., Brennan, A., Elliott, J., Boote, J., Emery, C., Baird, W., et al. (2014) · Programme Grants for Applied Research · doi:10.3310/pgfar02050 · Cited by 53
Self-citationCampbell, F., Lawton, J., Rankin, D., Clowes, M., Coates, E., Heller, S., de Zoysa, N., Elliott, J., & Breckenridge, J. P. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3655-z · Cited by 53
Self-citationChoudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52
“hypoglycaemia in up to 40% of individuals who reported IAH at baseline [59, 60].”
Self-citationHypoglycemia in diabetes: The dark side of diabetes treatment. A patient‐centered review
Johnson‐Rabbett, B., & Seaquist, E. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12933 · Cited by 55
“In a randomized cross-over design study including 161 patients with T1D treated with multiple daily insulin injections (MDI), daytime and nocturnal time with hypoglycemia was reduced by 16 minutes/day with the use of CGM compared with self-measurement of blood glucose.(29)”
MethodLittle, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Self-citationRoldan, V. D. T., Urtecho, M., Nayfeh, T., Firwana, M., Muthusamy, K., Hasan, B., Abd‐Rabu, R., Maraboto, A., Qoubaitary, A., Prokop, L. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac601 · Cited by 47
Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance
Amiel, S. A., Pursey, N., Higgins, B., & Dawoud, D. (2015) · BMJ · doi:10.1136/bmj.h4188 · Cited by 45
Self-citationAmiel, S. A., Choudhary, P., Jacob, P., Smith, E. L., De Zoysa, N., Gonder-Frederick, L., Kendall, M., Heller, S., Brooks, A., Toschi, E., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030356 · Cited by 41
Self-citationKruger, J., Brennan, A., Thokala, P., Basarir, H., Jacques, R., Elliott, J., Heller, S., & Speight, J. (2013) · Diabetic Medicine · doi:10.1111/dme.12270 · Cited by 42
Self-citationFear of hypoglycaemia in adults with Type 1 diabetes: results from Diabetes MILES – The Netherlands
Nefs, G., Bevelander, S., Hendrieckx, C., Bot, M., Ruige, J., Speight, J., & Pouwer, F. (2015) · Diabetic Medicine · doi:10.1111/dme.12739 · Cited by 37
Fonte, D., Apostolidis, T., & Lagouanelle-Simeoni, M.-C. (2015) · Santé Publique · doi:10.3917/spub.146.0763 · Cited by 47
Mohn, J., Graue, M., Aßmus, J., Zoffmann, V., Thordarson, H. B., Peyrot, M. F., & Rokne, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013295 · Cited by 40
Al‐Ozairi, E., Samad, A. E., Kandari, J. A., & Aldibbiat, A. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00849 · Cited by 44
“Several studies have reported improved HbA1C and quality of life without an increased risk of hypoglycemia (30, 31).”
BackgroundChoudhary, P., Campbell, F., Joule, N., Kar, P., & on behalf of Diabetes, U. K. (2019) · Diabetic Medicine · doi:10.1111/dme.13933 · Cited by 38
Lucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
On behalf of the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG), de Souza, A. C. C. B., Felício, J. S., Koury, C. C., Neto, J. F. A., Miléo, K. B., Santos, F. M., Negrato, C. A., Motta, A. R. B., da Silva, D. D., et al. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0396-0 · Cited by 43
“Results: The assessment of HRQoL by the EuroQol showed that the average score assigned to general health in Brazil is markedly lower than those found in two other Type 1 DM population-based studies conducted in Europe (EQ–VAS from the Netherlands, the United Kingdom and Brazil were 80.8 ± 15.2, 75.1 ± 18.4 and 72.5 ±…”
ResultInfluentialRecent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Iqbal, A., Novodvorský, P., & Heller, S. R. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.3 · Cited by 45
Self-citationAssessing quality of life in diabetes: II – Deconstructing measures into a simple framework
Tang, T. S., Yusuf, F. L. A., Polonsky, W. H., & Fisher, L. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.007 · Cited by 37
Hering, B. J., & O’Connell, P. J. (2016) · Xenotransplantation · doi:10.1111/xen.12228 · Cited by 37
Emotional intelligence and glycemic management among type I diabetes patients
Zysberg, L., Yoseph, T. B., & Goldman, M. (2015) · Journal of Health Psychology · doi:10.1177/1359105315596373 · Cited by 37
“Studies have demonstrated the effects of resources such as education, family and social support on effective management of glycemic levels, and other aspects of diabetic management (Freeborn, 2014; Hopkins et al., 2012).”
BackgroundRankin, D., Elliott, D., Heller, S. R., Amiel, S. A., Rogers, H., DeZoysa, N., & Lawton, J. (2013) · Chronic Illness · doi:10.1177/1742395313513911 · Cited by 38
“Awareness of hypoglycaemia is often variable but a degree of unawareness affects approximately 25% of people with Type 1 diabetes and this proportion rises to almost 50% amongst those diagnosed over 20 years.(8,9) Loss of awareness carries a threeto six-fold increase in risk of severe hypoglycaemia(8,10) and severe ep…”
BackgroundSelf-citationTodd, P. J., Edwards, F., Spratling, L., Patel, N. H., Amiel, S. A., Sturt, J., & Choudhary, P. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.3 · Cited by 35
Self-citationHeller, S. R., Gianfrancesco, C., Taylor, C., & Elliott, J. (2020) · Diabetic Medicine · doi:10.1111/dme.14268 · Cited by 35
Self-citationGhandi, K., Pieri, B., Dornhorst, A., & Hussain, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00965-0 · Cited by 34
Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies
Kaur, J., & Seaquist, E. R. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00762-8 · Cited by 38
Stanton‐Fay, S. H., Hamilton, K., Chadwick, P. M., Lorencatto, F., Gianfrancesco, C., de Zoysa, N., Coates, E., Cooke, D., McBain, H., Heller, S. R., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14548 · Cited by 33
“10 Participation in the DAFNE programme improves glycated haemoglobin (HbA1c) in the short term, 11,12 although initial improvements are often not sustained beyond 6– 12 months (13, 14, although see,15).”
BackgroundSelf-citationThomas, R., Alabraba, V., Barnard, S., Beba, H., Brake, J., Cox, A., Bowker, R., Edwards, D., Epps, A., Fletcher-Salt, T., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211054862 · Cited by 34
Clinical approaches to treat impaired awareness of hypoglycaemia
Farrell, C. M., & McCrimmon, R. J. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211000248 · Cited by 31
Diabetes, trekking and high altitude: recognizing and preparing for the risks
Mohajeri, S., Perkins, B. A., Brubaker, P. L., & Riddell, M. C. (2015) · Diabetic Medicine · doi:10.1111/dme.12795 · Cited by 34
Sepúlveda, E., Poínhos, R., Nata, G., Carvalho, D. M., Neves, J. S., Seixas, D., Choudhary, P., Vicente, S., & Amiel, S. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0034 · Cited by 32
Self-citationIslet Cell Transplantion: Update on Current Clinical Trials
Schuetz, C., & Markmann, J. F. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0103-z · Cited by 34
Humayun, M. A., Jenkins, E., Knott, J., Ryder, J., Shaban, C., Weiß, M., Charman, J., Cavan, D. A., & Brooks, A. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.034 · Cited by 32
Joshi, M., & Choudhary, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0644-z · Cited by 32
Donzeau, A., Bonnemaison, É., Vautier, V., Menut, V., Houdon, L., Bendelac, N., Bismuth, É., Bouhours‐Nouet, N., Quemener, E., Baron, S., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13076 · Cited by 29
Elliott, D., Rankin, D., Jacques, R., Lawton, J., Emery, C., Campbell, M. J., Dixon, S., & Heller, S. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12621 · Cited by 28
Self-citationWalker, G. S., Chen, J. Y., Hopkinson, H., Sainsbury, C. A. R., & Jones, G. C. (2018) · Diabetic Medicine · doi:10.1111/dme.13621 · Cited by 30
PAID-11: A brief measure of diabetes distress validated in adults with type 1 diabetes
Stanulewicz, N., Mansell, P., Cooke, D. D., Hopkins, D., Speight, J., & Blake, H. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.026 · Cited by 28
Self-citationChatwin, H., Broadley, M. M., Hendrieckx, C., Carlton, J., Heller, S. R., Amiel, S. A., de Galan, B. E., McCrimmon, R. J., Pedersen‐Bjergaard, U., Pouwer, F., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108232 · Cited by 28
“Clinical Characteristics Age of T1DM onset, years 16 [9-30] T1DM duration, years 25 [14-39] Primary diabetes management regimen Multiple daily injections 44% (447) Insulin pump 40% (409) Artificial pancreas/closed-loop systems (CLS) 16% (166)”
BackgroundSelf-citationFrequency, Causes and Risk Factors for Hypoglycaemia in Type 1 Diabetes
Strachan, M. W. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch4 · Cited by 27
Özcan, Ş., Amiel, S. A., Rogers, H., Choudhary, P., Cox, A., de Zoysa, N., Hopkins, D., & Forbes, A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.023 · Cited by 28
Self-citation
Metadata
- Authors
- Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S.
- Affiliations
- National Health Service (GB)
- University of Nottingham (GB)
- Northumbria Healthcare NHS Foundation Trust (GB)
- King's College London (GB)
- University of Sheffield (GB)
- Corresponding author
- Hopkins, David
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-07-14
- Volume
- 35
- Issue
- 8
- Pages
- 1638-1642
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3402270
- OpenAlex
- W2101618628
- Cited by
- 265
- References
- 19
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 17 · 2023: 10 · 2022: 20 · 2021: 24 · 2020: 25 · 2019: 22 · 2018: 21 · 2017: 20 · 2016: 19 · 2015: 26 · 2014: 17 · 2013: 23 · 2012: 6
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (RP-PG-0606-1184)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, DAΦNE, structured education, glycemic control, HbA1c, severe hypoglycemia, hypoglycemia awareness, psychological distress, anxiety, depression, quality of life, routine clinical practice, diabetes self-management education, weight change, Problem Areas in Diabetes, Hospital Anxiety and Depression Scale, EuroQol-5D
- MeSH terms
- Adult, Anxiety, Depression, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Patient Education as Topic, Surveys and Questionnaires, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.